BioSyent Inc. (TSXV:RX)

BioSyent Statistics

Total Valuation

BioSyent has a market cap or net worth of CAD 165.17 million. The enterprise value is 159.52 million.

Market Cap	165.17M
Enterprise Value	159.52M

Important Dates

The last earnings date was Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	May 29, 2026

Share Statistics

BioSyent has 11.44 million shares outstanding. The number of shares has decreased by -1.64% in one year.

Current Share Class	11.44M
Shares Outstanding	11.44M
Shares Change (YoY)	-1.64%
Shares Change (QoQ)	+0.77%
Owned by Insiders (%)	9.82%
Owned by Institutions (%)	19.50%
Float	9.23M

Valuation Ratios

The trailing PE ratio is 18.42 and the forward PE ratio is 15.53.

PE Ratio	18.42
Forward PE	15.53
PS Ratio	3.59
PB Ratio	3.67
P/TBV Ratio	8.51
P/FCF Ratio	13.32
P/OCF Ratio	13.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.80, with an EV/FCF ratio of 12.86.

EV / Earnings	17.65
EV / Sales	3.47
EV / EBITDA	12.80
EV / EBIT	14.05
EV / FCF	12.86

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.12.

Current Ratio	1.89
Quick Ratio	1.11
Debt / Equity	0.12
Debt / EBITDA	0.42
Debt / FCF	0.42
Interest Coverage	167.28

Financial Efficiency

Return on equity (ROE) is 22.31% and return on invested capital (ROIC) is 31.84%.

Return on Equity (ROE)	22.31%
Return on Assets (ROA)	13.48%
Return on Invested Capital (ROIC)	31.84%
Return on Capital Employed (ROCE)	24.72%
Weighted Average Cost of Capital (WACC)	7.57%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.87
Inventory Turnover	1.35

Taxes

In the past 12 months, BioSyent has paid 3.12 million in taxes.

Income Tax	3.12M
Effective Tax Rate	25.68%

Stock Price Statistics

The stock price has increased by +34.33% in the last 52 weeks. The beta is 0.64, so BioSyent's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	+34.33%
50-Day Moving Average	14.92
200-Day Moving Average	12.90
Relative Strength Index (RSI)	42.93
Average Volume (20 Days)	5,802

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioSyent had revenue of CAD 45.98 million and earned 9.04 million in profits. Earnings per share was 0.78.

Revenue	45.98M
Gross Profit	34.79M
Operating Income	11.35M
Pretax Income	12.16M
Net Income	9.04M
EBITDA	12.33M
EBIT	11.35M
Earnings Per Share (EPS)	0.78

Balance Sheet

The company has 10.90 million in cash and 5.25 million in debt, with a net cash position of 5.65 million or 0.49 per share.

Cash & Cash Equivalents	10.90M
Total Debt	5.25M
Net Cash	5.65M
Net Cash Per Share	0.49
Equity (Book Value)	44.99M
Book Value Per Share	3.97
Working Capital	14.76M

Cash Flow

In the last 12 months, operating cash flow was 12.45 million and capital expenditures -47,351, giving a free cash flow of 12.40 million.

Operating Cash Flow	12.45M
Capital Expenditures	-47,351
Depreciation & Amortization	978,123
Net Borrowing	3.76M
Free Cash Flow	12.40M
FCF Per Share	1.08

Margins

Gross margin is 75.67%, with operating and profit margins of 24.69% and 19.65%.

Gross Margin	75.67%
Operating Margin	24.69%
Pretax Margin	26.44%
Profit Margin	19.65%
EBITDA Margin	26.82%
EBIT Margin	24.69%
FCF Margin	26.97%

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 1.52%.

Dividend Per Share	0.22
Dividend Yield	1.52%
Dividend Growth (YoY)	10.53%
Years of Dividend Growth	4
Payout Ratio	25.54%
Buyback Yield	1.64%
Shareholder Yield	3.16%
Earnings Yield	5.47%
FCF Yield	7.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4